Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant Klebsiella pneumoniae Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility
- 1Department of Medical Microbiology, Kahramanmaraş Necip Fazıl City Hospital, 46000 Kahramanmaraş, Türkiye
- 2Department of Microbiology, University of Health Sciences Van Training and Research Hospital, 65300 Van, Türkiye
Abstract
Carbapenem-resistant Klebsiella pneumoniae (CR-Kp) is a major healthcare-associated pathogen, and the coexistence of different carbapenemases may complicate phenotypic detection and antimicrobial treatment. This study evaluated carbapenemase profiles in 123 CR-Kp isolates from two centers in Türkiye and compared the modified carbapenem inactivation method (mCIM) and EDTA-modified carbapenem inactivation method (eCIM) with multiplex real-time PCR targeting KPC, NDM, VIM, IMP, and OXA-48. Ceftazidime-avibactam (CZA) and colistin susceptibility were also assessed. Carbapenemase genes were detected in 122/123 isolates (99.2%), predominantly NDM + OXA-48 (45.5%), followed by OXA-48 alone (26.8%), KPC alone (18.7%), and NDM alone (8.1%). mCIM showed 99.2% sensitivity, whereas eCIM showed 87.7% sensitivity and 100% specificity for NDM detection. All eight false-negative eCIM results occurred among NDM + OXA-48 co-producing isolates (8/55), whereas no false-negative results were observed among isolates carrying NDM alone (0/10); this difference was not statistically significant (p = 0.339). CZA resistance was observed in 49.6% of isolates, with a higher likelihood of resistance among NDM-positive isolates in the exploratory analysis (OR, 9.03; 95% CI, 3.97–20.54; p < 0.001). Colistin resistance was observed in 36.6% of isolates, with no statistically significant association with carbapenemase profiles in the analyses performed. These exploratory findings suggest that combined molecular and phenotypic testing may be useful for carbapenemase characterization and highlight the occurrence of false-negative eCIM results in some NDM + OXA-48 co-producing isolates. Given the absence of adjustment for multiple comparisons, the observed associations should be interpreted cautiously and considered hypothesis-generating.
Related
- Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam
- Investigation on the use of ceftazidime-avibactam at a national hospital in Vietnam
- Longitudinal Multicenter Susceptibility Trends of Ceftazidime/Avibactam and Imipenem/Relebactam and Dose Optimization in Critically Ill Patients with Carbapenem-Resistant Enterobacterales Bloodstream Infections
- Availability of genotypic and phenotypic drug susceptibility testing for Mycobacterium tuberculosis in WHO European Region
- MPT64 secretion as a viability-associated immunoassay readout for rapid phenotypic drug susceptibility classification of Mycobacterium tuberculosis: a proof-of-concept study
BibTeX
@article{torun2026phenotypic,
title = {{Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant Klebsiella pneumoniae Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility}},
author = {Elif Gülsüm Torun and Elif Okumuş and Esra Kaya},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209307},
url = {https://www.mdpi.com/1422-0067/27/20/9307},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant Klebsiella pneumoniae Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility
AU - Elif Gülsüm Torun
AU - Elif Okumuş
AU - Esra Kaya
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209307
UR - https://www.mdpi.com/1422-0067/27/20/9307
AB - Carbapenem-resistant Klebsiella pneumoniae (CR-Kp) is a major healthcare-associated pathogen, and the coexistence of different carbapenemases may complicate phenotypic detection and antimicrobial treatment. This study evaluated carbapenemase profiles in 123 CR-Kp isolates from two centers in Türkiye and compared the modified carbapenem inactivation method (mCIM) and EDTA-modified carbapenem inactivation method (eCIM) with multiplex real-time PCR targeting KPC, NDM, VIM, IMP, and OXA-48. Ceftazidime-avibactam (CZA) and colistin susceptibility were also assessed. Carbapenemase genes were detected in 122/123 isolates (99.2%), predominantly NDM + OXA-48 (45.5%), followed by OXA-48 alone (26.8%), KPC alone (18.7%), and NDM alone (8.1%). mCIM showed 99.2% sensitivity, whereas eCIM showed 87.7% sensitivity and 100% specificity for NDM detection. All eight false-negative eCIM results occurred among NDM + OXA-48 co-producing isolates (8/55), whereas no false-negative results were observed among isolates carrying NDM alone (0/10); this difference was not statistically significant (p = 0.339). CZA resistance was observed in 49.6% of isolates, with a higher likelihood of resistance among NDM-positive isolates in the exploratory analysis (OR, 9.03; 95% CI, 3.97–20.54; p < 0.001). Colistin resistance was observed in 36.6% of isolates, with no statistically significant association with carbapenemase profiles in the analyses performed. These exploratory findings suggest that combined molecular and phenotypic testing may be useful for carbapenemase characterization and highlight the occurrence of false-negative eCIM results in some NDM + OXA-48 co-producing isolates. Given the absence of adjustment for multiple comparisons, the observed associations should be interpreted cautiously and considered hypothesis-generating.
SN - 1422-0067
ER -